2020
DOI: 10.1007/s11481-020-09970-3
|View full text |Cite
|
Sign up to set email alerts
|

An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 101 publications
0
2
0
Order By: Relevance
“…TIMP-1 belongs to a family of cytokines that are expressed in response to multiple cytokine release in tissues and are well known for their role in extracellular remodeling by inhibiting matrix metalloproteinases ( 80 ). Identifying molecular profiles (preferably in serum, plasma or on circulating leukocytes) at well-defined disease stages in these peripheral neuropathies using transcriptomics ( 81 ), proteomics ( 82 ), flow cytometry or a combination thereof, supported by bioinformatics analyses to detect pathway similarities and differences, could advance current knowledge. This may lead to more disease-targeted personalized treatments and more precise objective disease measures in chronic neuropathic pain.…”
Section: Discussionmentioning
confidence: 99%
“…TIMP-1 belongs to a family of cytokines that are expressed in response to multiple cytokine release in tissues and are well known for their role in extracellular remodeling by inhibiting matrix metalloproteinases ( 80 ). Identifying molecular profiles (preferably in serum, plasma or on circulating leukocytes) at well-defined disease stages in these peripheral neuropathies using transcriptomics ( 81 ), proteomics ( 82 ), flow cytometry or a combination thereof, supported by bioinformatics analyses to detect pathway similarities and differences, could advance current knowledge. This may lead to more disease-targeted personalized treatments and more precise objective disease measures in chronic neuropathic pain.…”
Section: Discussionmentioning
confidence: 99%
“…The sensitivity, specificity, and wide dynamic range for detection of low-abundance secreted peptides makes MS exceptionally well suited for profiling as well as the structural and quantitative characterization of the peptidome in various models, and enables further discovery of pharmacological targets. Secretomics studies, most often based on liquid chromatography-MS/MS technology, have been applied to the analysis of neuropeptides in releasates from cell and organ cultures, brain microdialysates, and cerebrospinal fluid (Bernay et al, 2009;Yin et al, 2012;Tillmaand et al, 2015;Gahoi and Gautam, 2016;Al-Hasani et al, 2018;Beumer et al, 2020;Royds et al, 2021).…”
Section: A Decoding Chemical Signalingmentioning
confidence: 99%